-       Report 
- August 2023
-  133 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- September 2022
-  86 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- September 2025
-  282 Pages 
-  Brazil, China, India, ... Brazil, China, India, Russia  
   From       €5362EUR$5,995USD£4,717GBP 
          -       Report 
- June 2025
-  152 Pages 
- China 
   From       €4468EUR$4,995USD£3,930GBP 
          -       Report 
- March 2024
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
           -       Report 
- March 2024
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
          -       Report 
- May 2023
-  132 Pages 
- Global 
   From       €850EUR$950USD£747GBP 
          -       Report 
- November 2021
-  1112 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
             The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD    applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less   Read more